“gv” Archives

in
Entry Author Date Location
Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs 09/24/20 Boston
Freenome Tacks on $270M to Advance Blood Tests to Find Cancer Early 08/26/20 San Francisco
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes 06/11/20 Boston
Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development 05/26/20 San Francisco
Ventus Launches With $60M to Shine Light on Innate Immune System Drugs 05/06/20 Boston
At Rome Therapeutics, Kapeller Aims to Turn “Junk” Into New Drugs 04/28/20 Boston
Cerevance Raises $45M to Advance Brain Disease Research & Development 04/14/20 Boston
Challenging CRISPR, Trucode Raises $34M for New Gene-Editing System 09/10/19 San Francisco
Freenome Snags $160M to Boost Blood Test for Early Cancer Detection 07/24/19 San Francisco
TScan Lands $48M for Better, Safer T-Cell Receptor Cancer Therapies 07/24/19 Boston
Kronos Bio Reels In $105M for Drugs That Hit “Undruggable” Targets 07/18/19 San Francisco
Locana, Fueled With $55M, Looks to Develop Fixes for Faulty RNA 06/21/19 San Diego
Can AI Tools, $76M Lead BlackThorn to Targeted Psych Drugs? 06/13/19 San Francisco
Recorded Future Bought for $780M in Latest Boston Cybersecurity Deal 05/30/19 Boston
Ideaya and Bicycle Therapeutics IPOs Raise $110M for Cancer Drug R&D 05/23/19 San Francisco
Cala Health Secures $50M to Launch Anti-Tremor Wrist Device 05/22/19 San Francisco
Verve Has Top Cardio-Geneticist, $58.5M to Aim CRISPR at Heart Attacks 05/07/19 Boston
It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help 04/18/19 Boston
Business Travel Startup Lola Raises $37M to Double Headcount in Boston 03/26/19 Boston
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Al Gore: Coming Tech Revolution Could Take More Jobs Than It Makes 03/06/19 Boston
Women Who Code in Houston, Sam’s Club, Springdale & More TX Tech 03/04/19 Texas
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans 02/28/19 San Francisco
Carmera, Toyota Research Institute Zoom Ahead on AV Mapping Project 02/28/19 Detroit Ann Arbor
With $191M Haul, Maze Therapeutics Takes Aim at Genetic Diseases 02/28/19 San Francisco
Bill Maris’s VC Firm Section 32 Raises $200M for Second Fund 02/25/19 San Diego
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More 02/15/19 National
GV Taps Ex-Agios CEO Schenkein to Lead Life Science Investments 02/11/19 San Francisco
“At a Critical Juncture,” Desktop Metal Gets $160M From Koch Fund 01/23/19 Boston
A Healthier Lifestyle Helped Lead This Tech Exec to His Next Venture 01/22/19 Texas
Page 1 of 4 next page »